Tetrahydroisoquinolines as dopaminergic ligands: 1-Butyl-7-chloro-6-hydroxy-tetrahydroisoquinoline, a new compound with antidepressant-like activity in mice

Bioorganic and Medicinal Chemistry

Volumn 17, Issue 14, 2009, Pages 4968-4980

  Berenguer, Inmaculada ^a   Aouad, Noureddine El ^a   Andujar, Sebastián ^b,c   Romero, Vanessa ^a   Suvire, Fernando ^b   Freret, Thomas ^d   Bermejo, Almudena ^a,e   Ivorra, María Dolores ^a   Enriz, Ricardo D ^b,c   Boulouard, Michel ^d   Cabedo, Nuria ^a,f   Cortes, Diego ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSIDAD NACIONAL DE SAN LUIS   (Argentina)

^c Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^d UNIVERSITÉ DE CAEN   (France)

^e INSTITUTO VALENCIANO DE INVESTIGACIONES AGRARIAS IVIA   (Spain)

^f UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

Author keywords

Dopamine receptors; In vivo behavioral assays; Structure activity relationships; Tetrahydroisoquinolines; Theoretical calculations

Indexed keywords

1 BUTYL 7 CHLORO 6 HYDROXYTETRAHYDROISOQUINOLINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; HALOPERIDOL; TETRAHYDROISOQUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; FORCED SWIMMING TEST; LOCOMOTION; MALE; MOUSE; NONHUMAN; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION; SYNAPTOSOME;

ANIMALS; ANTIDEPRESSIVE AGENTS; CORPUS STRIATUM; DOPAMINE; HYDROXYQUINOLINES; LIGANDS; MALE; MICE; MODELS, MOLECULAR; MOTOR ACTIVITY; PROTEIN BINDING; RATS; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; STRUCTURE-ACTIVITY RELATIONSHIP; TETRAHYDROISOQUINOLINES;

MUS;

EID: 67650080277     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2009.05.079     Document Type: Article

References (36)

1. Oloff S., Mailman R.B., and Tropsha A. J. Med. Chem. 48 (2005) 7322
2. Sit S.-Y., Xie K., Jacutin-Porte S., Boy K.M., Seanz J., Taber M.T., Gulwadi A.G., Korpinen C.D., Burris K.D., Molski T.F., Ryan E., Xu C., Verdoorn T., Johnson G., Nichols D.E., and Mailman R.B. Bioorg. Med. Chem. 12 (2004) 715
3. Poewe W. Neurology 72 (2009) S65
4. Kvernmo T., Härtter S., and Bürger E. Clin. Ther. 28 (2006) 1065
5. Millan M.J., Maiofiss L., Cussac D., Audinot V., Boutin J.A., and Newman-Tancredi A.J. Pharmacol. Exp. Ther. 303 (2002) 791
6. Clausius N., Born C., and Grunze H. Neuropsychiatry 23 (2009) 15
7. Basso A.M., Gallagher K.B., Bratcher N.A., Brioni J.D., Moreland R.B., Hsieh G.C., Drescher K., Fox G.B., Decker M.W., and Rueter L.E. Neuropsychopharmacology 30 (2005) 1257
8. Brocco M., Dekeyne A., Papp M., and Millan M.J. Behav. Pharmacol. 17 (2006) 559
9. Kitagawa K., Kitamura Y., Miyazaki T., Miyaoka J., Kawasaki H., Asanuma M., and Sendo T. Naunyn Schmiedebergs Arch. Pharmacol. Mar (2009) 10
10. Zhang A., Zhang Y., Branfman A.R., Baldessarini R.J., and Neumeyer J.L. J. Med. Chem. 50 (2007) 171
11. Zhang A., Neumeyer J.L., and Baldessarini R.J. Chem. Rev. 107 (2007) 274
12. Protais P., Arbaoui J., Bakkali E.H., Bermejo A., and Cortes D.J. Nat. Prod. 58 (1995) 1475
13. Bermejo A., Protais P., Blázquez M.A., Rao K.S., Zafra-Polo M.C., and Cortes D. Nat. Prod. Lett. 6 (1995) 57
14. Cabedo N., Protais P., Cassels B.K., and Cortes D.J. Nat. Prod. 61 (1998) 709
15. Cabedo N., Andreu I., Ramírez de Arellano M.C., Chagraoui A., Serrano A., Bermejo A., Protais P., and Cortes D.J. Med. Chem. 44 (2001) 1794
16. Andreu I., Cabedo N., Torres G., Chagraoui A., Ramirez de Arellano M.C., Gil S., Bermejo A., Valpuesta M., Portais P., and Cortes D. Tetrahedron 58 (2002) 10173
17. Bermejo A., Andreu I., Suvire F., Léonce S., Caignard D.H., Renard P., Pierré A., Enriz R.D., Cortes D., and Cabedo N.J. Med. Chem. 45 (2002) 5058
18. Suvire F.D., Andreu I., Bermejo A., Zamora M.A., Cortes D., and Enriz R.D. J. Mol. Struct. (THEOCHEM) (2003) 666 109-116
19. Suvire F.D., Cabedo N., Chagraoui A., Zamora M.A., Cortes D., and Enriz R.D. J. Mol. Struct. (THEOCHEM) (2003) 666 455-467
20. Andreu I., Cortes D., Protais P., Cassels B.K., Chagraoui A., and Cabedo N. Bioorg. Med. Chem. 8 (2000) 889
21. Brown P.L., Bae D., and Kiyatkin E.A. Neuroscience 145 (2007) 335
22. Siuciak J.A., and Fujiwara R.A. Psychopharmacology (Berl) 175 (2004) 163
23. Fodor G., Gal J., and Phillips B.A. Angew. Chem., Int. Ed. Engl. 11 (1972) 919
24. Charifson P.S., Wyrick S.D., Hoffman A.J., Simmons R.M.A., Bowen J.P., McDougald D.L., and Mailman R.B.J. Med. Chem. 31 (1988) 1941
25. Minor D.L., Wyrick S.D., Charifson P.S., Watts V.J., Nichols D.E., and Mailman R.B.J. Med. Chem. 37 (1994) 4317
26. Doi S., Shirai N., and Sato Y. J. Chem. Soc., Perkin Trans. 1 (1997) 2217
27. Teeter M.M., Froimowitz M.F., Stec B., and DuRand C.J.J. Med. Chem. 37 (1994) 2874
28. Mansour A., Meng F., Meador-Woodruff J.H., Taylor L.P., Civelli O., and Akil H. Eur. J. Pharmacol. 227 (1992) 205
29. Hjerde E., Dahl S.G., and Sylte I. Eur. J. Med. Chem. 40 (2005) 185
30. Charifson P.S., Bowen J.P., Wyrick S.D., Hoffman A.J., Cory M., McPhail A.T., and Mailman R.B.J. Med. Chem. 32 (1989) 2050
31. Boissier J.R., and Simon P. Arch. Int. Pharmacodyn. Ther. 158 (1965) 212
32. Porsolt R.D., Bertin A., and Jalfre M. Arch. Int. Pharmacodyn. Ther. 229 (1977) 327
33. Aguila B., Coulbault L., Boulouard M., Léveillé F., Davis A., Tóth G., Borsodi A., Balboni G., Salvadori S., Jauzac P., and Allouche S. Br. J. Pharmacol. 152 (2007) 1312
34. Neve K.A., Cumbay M.G., Thompson K.R., Yang R., Buck D.C., Watts V.J., DuRand C.J., and Teeter M.M. Mol. Pharmacol. 60 (2001) 373
35. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Montgomery, J. A. Jr.; Vreven, T.; Kudin, K. N.; Burant, J. C.; Millam, J. M.; Iyengar, S. S.; Tomasi, J.; Barone, V.; Mennucci, B.; Cossi, M.; Scalmani, G.; Rega, N.; Petersson, G. A.; Nakatsuji, H.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Klene, M.; Li, X.; Knox, J. E.; Hratchian, H. P.; Cross, J. B.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Ayala, P. Y.; Morokuma, K.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, M. C.; Farkas, O.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Ortiz, J. V.; Cui, Q.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Martin, R. L.; Fox, D. J.; Keith, T.; .Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Gonzalez, C.; Pople, J. A. In gaussian 03, Revision B.05 2003, Gaussian, Inc.: Pittsburgh PA.
36. Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., and Ferrin T.E. J. Comput. Chem. 25 (2004) 1605